Cancer immunotherapy (sometimes called immuno-oncology) is the use of the immune system to treat cancer.

Scope of the Report:

This report focuses on the Immuno-oncology Therapy in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa. This report categorizes the market based on manufacturers, regions, type and application.

The worldwide market for Immuno-oncology Therapy is expected to grow at a CAGR of roughly xx% over the next five years, will reach xx million US$ in 2023, from xx million US$ in 2017, according to a new GIR (Global Info Research) study.

Market Segment by Manufacturers, this report covers

Amgen

AstraZeneca

Bristol-Myers Squibb

Eli-Lilly

Roche

GlaxoSmithKline

Janssen Biotech

Merck

Novartis

Pfizer

Sanofi

Spectrum Pharmaceuticals

Takeda 

Market Segment by Regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia and Italy)

Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

South America (Brazil, Argentina, Colombia etc.)

Middle East and Africa (Saudi Arabia, UAE, Egypt, Nigeria and South Africa)

Market Segment by Type, covers

Monoclonal Antibodies

Immune Checkpoint Inhibitors

Immune System Modulators

Cancer Vaccines

Others

Market Segment by Applications, can be divided into

Hospitals

Ambulatory Surgical Center

Others

There are 15 Chapters to deeply display the global Immuno-oncology Therapy market.

Chapter 1, to describe Immuno-oncology Therapy Introduction, product scope, market overview, market opportunities, market risk, market driving force;

Chapter 2, to analyze the top manufacturers of Immuno-oncology Therapy, with sales, revenue, and price of Immuno-oncology Therapy, in 2016 and 2017;

Chapter 3, to display the competitive situation among the top manufacturers, with sales, revenue and market share in 2016 and 2017;

Chapter 4, to show the global market by regions, with sales, revenue and market share of Immuno-oncology Therapy, for each region, from 2013 to 2018;

Chapter 5, 6, 7, 8 and 9, to analyze the market by countries, by type, by application and by manufacturers, with sales, revenue and market share by key countries in these regions;

Chapter 10 and 11, to show the market by type and application, with sales market share and growth rate by type, application, from 2013 to 2018;

Chapter 12, Immuno-oncology Therapy market forecast, by regions, type and application, with sales and revenue, from 2018 to 2023;

Chapter 13, 14 and 15, to describe Immuno-oncology Therapy sales channel, distributors, traders, dealers, Research Findings and Conclusion, appendix and data source

Table of Contents

1 Market Overview

1.1 Immuno-oncology Therapy Introduction

1.2 Market Analysis by Type

1.2.1 Monoclonal Antibodies

1.2.2 Immune Checkpoint Inhibitors

1.2.3 Immune System Modulators

1.2.4 Cancer Vaccines

1.2.5 Others

1.3 Market Analysis by Applications

1.3.1 Hospitals

1.3.2 Ambulatory Surgical Center

1.3.3 Others

1.4 Market Analysis by Regions

1.4.1 North America (United States, Canada and Mexico)

1.4.1.1 United States Market States and Outlook (2013-2023)

1.4.1.2 Canada Market States and Outlook (2013-2023)

1.4.1.3 Mexico Market States and Outlook (2013-2023)

1.4.2 Europe (Germany, France, UK, Russia and Italy)

1.4.2.1 Germany Market States and Outlook (2013-2023)

1.4.2.2 France Market States and Outlook (2013-2023)

1.4.2.3 UK Market States and Outlook (2013-2023)

1.4.2.4 Russia Market States and Outlook (2013-2023)

1.4.2.5 Italy Market States and Outlook (2013-2023)

1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)

1.4.3.1 China Market States and Outlook (2013-2023)

1.4.3.2 Japan Market States and Outlook (2013-2023)

1.4.3.3 Korea Market States and Outlook (2013-2023)

1.4.3.4 India Market States and Outlook (2013-2023)

1.4.3.5 Southeast Asia Market States and Outlook (2013-2023)

1.4.4 South America, Middle East and Africa

1.4.4.1 Brazil Market States and Outlook (2013-2023)

1.4.4.2 Egypt Market States and Outlook (2013-2023)

1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023)

1.4.4.4 South Africa Market States and Outlook (2013-2023)

1.4.4.5 Nigeria Market States and Outlook (2013-2023)

1.5 Market Dynamics

1.5.1 Market Opportunities

1.5.2 Market Risk

1.5.3 Market Driving Force

2 Manufacturers Profiles

2.1 Amgen

2.1.1 Business Overview

2.1.2 Immuno-oncology Therapy Type and Applications

2.1.2.1 Product A

2.1.2.2 Product B

2.1.3 Amgen Immuno-oncology Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.2 AstraZeneca

2.2.1 Business Overview

2.2.2 Immuno-oncology Therapy Type and Applications

2.2.2.1 Product A

2.2.2.2 Product B

2.2.3 AstraZeneca Immuno-oncology Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.3 Bristol-Myers Squibb

2.3.1 Business Overview

2.3.2 Immuno-oncology Therapy Type and Applications

2.3.2.1 Product A

2.3.2.2 Product B

2.3.3 Bristol-Myers Squibb Immuno-oncology Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.4 Eli-Lilly

2.4.1 Business Overview

2.4.2 Immuno-oncology Therapy Type and Applications

2.4.2.1 Product A

2.4.2.2 Product B

2.4.3 Eli-Lilly Immuno-oncology Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.5 Roche

2.5.1 Business Overview

2.5.2 Immuno-oncology Therapy Type and Applications

2.5.2.1 Product A

2.5.2.2 Product B

2.5.3 Roche Immuno-oncology Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.6 GlaxoSmithKline

2.6.1 Business Overview

2.6.2 Immuno-oncology Therapy Type and Applications

2.6.2.1 Product A

2.6.2.2 Product B

2.6.3 GlaxoSmithKline Immuno-oncology Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.7 Janssen Biotech

2.7.1 Business Overview

2.7.2 Immuno-oncology Therapy Type and Applications

2.7.2.1 Product A

2.7.2.2 Product B

2.7.3 Janssen Biotech Immuno-oncology Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.8 Merck

2.8.1 Business Overview

2.8.2 Immuno-oncology Therapy Type and Applications

2.8.2.1 Product A

2.8.2.2 Product B

2.8.3 Merck Immuno-oncology Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.9 Novartis

2.9.1 Business Overview

2.9.2 Immuno-oncology Therapy Type and Applications

2.9.2.1 Product A

2.9.2.2 Product B

2.9.3 Novartis Immuno-oncology Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.10 Pfizer

2.10.1 Business Overview

2.10.2 Immuno-oncology Therapy Type and Applications

2.10.2.1 Product A

2.10.2.2 Product B

2.10.3 Pfizer Immuno-oncology Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.11 Sanofi

2.11.1 Business Overview

2.11.2 Immuno-oncology Therapy Type and Applications

2.11.2.1 Product A

2.11.2.2 Product B

2.11.3 Sanofi Immuno-oncology Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.12 Spectrum Pharmaceuticals

2.12.1 Business Overview

2.12.2 Immuno-oncology Therapy Type and Applications

2.12.2.1 Product A

2.12.2.2 Product B

2.12.3 Spectrum Pharmaceuticals Immuno-oncology Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

2.13 Takeda 

2.13.1 Business Overview

2.13.2 Immuno-oncology Therapy Type and Applications

2.13.2.1 Product A

2.13.2.2 Product B

2.13.3 Takeda  Immuno-oncology Therapy Sales, Price, Revenue, Gross Margin and Market Share (2016-2017)

3 Global Immuno-oncology Therapy Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017)

3.1 Global Immuno-oncology Therapy Sales and Market Share by Manufacturer (2016-2017)

3.2 Global Immuno-oncology Therapy Revenue and Market Share by Manufacturer (2016-2017)

3.3 Market Concentration Rate

3.3.1 Top 3 Immuno-oncology Therapy Manufacturer Market Share in 2017

3.3.2 Top 6 Immuno-oncology Therapy Manufacturer Market Share in 2017

3.4 Market Competition Trend

4 Global Immuno-oncology Therapy Market Analysis by Regions

4.1 Global Immuno-oncology Therapy Sales, Revenue and Market Share by Regions

4.1.1 Global Immuno-oncology Therapy Sales and Market Share by Regions (2013-2018)

4.1.2 Global Immuno-oncology Therapy Revenue and Market Share by Regions (2013-2018)

4.2 North America Immuno-oncology Therapy Sales and Growth Rate (2013-2018)

4.3 Europe Immuno-oncology Therapy Sales and Growth Rate (2013-2018)

4.4 Asia-Pacific Immuno-oncology Therapy Sales and Growth Rate (2013-2018)

4.5 South America Immuno-oncology Therapy Sales and Growth Rate (2013-2018)

4.6 Middle East and Africa Immuno-oncology Therapy Sales and Growth Rate (2013-2018)

5 North America Immuno-oncology Therapy by Countries

5.1 North America Immuno-oncology Therapy Sales, Revenue and Market Share by Countries

5.1.1 North America Immuno-oncology Therapy Sales and Market Share by Countries (2013-2018)

5.1.2 North America Immuno-oncology Therapy Revenue and Market Share by Countries (2013-2018)

5.2 United States Immuno-oncology Therapy Sales and Growth Rate (2013-2018)

5.3 Canada Immuno-oncology Therapy Sales and Growth Rate (2013-2018)

5.4 Mexico Immuno-oncology Therapy Sales and Growth Rate (2013-2018)

6 Europe Immuno-oncology Therapy by Countries

6.1 Europe Immuno-oncology Therapy Sales, Revenue and Market Share by Countries

6.1.1 Europe Immuno-oncology Therapy Sales and Market Share by Countries (2013-2018)

6.1.2 Europe Immuno-oncology Therapy Revenue and Market Share by Countries (2013-2018)

6.2 Germany Immuno-oncology Therapy Sales and Growth Rate (2013-2018)

6.3 UK Immuno-oncology Therapy Sales and Growth Rate (2013-2018)

6.4 France Immuno-oncology Therapy Sales and Growth Rate (2013-2018)

6.5 Russia Immuno-oncology Therapy Sales and Growth Rate (2013-2018)

6.6 Italy Immuno-oncology Therapy Sales and Growth Rate (2013-2018)

7 Asia-Pacific Immuno-oncology Therapy by Countries

7.1 Asia-Pacific Immuno-oncology Therapy Sales, Revenue and Market Share by Countries

7.1.1 Asia-Pacific Immuno-oncology Therapy Sales and Market Share by Countries (2013-2018)

7.1.2 Asia-Pacific Immuno-oncology Therapy Revenue and Market Share by Countries (2013-2018)

7.2 China Immuno-oncology Therapy Sales and Growth Rate (2013-2018)

7.3 Japan Immuno-oncology Therapy Sales and Growth Rate (2013-2018)

7.4 Korea Immuno-oncology Therapy Sales and Growth Rate (2013-2018)

7.5 India Immuno-oncology Therapy Sales and Growth Rate (2013-2018)

7.6 Southeast Asia Immuno-oncology Therapy Sales and Growth Rate (2013-2018)

8 South America Immuno-oncology Therapy by Countries

8.1 South America Immuno-oncology Therapy Sales, Revenue and Market Share by Countries

8.1.1 South America Immuno-oncology Therapy Sales and Market Share by Countries (2013-2018)

8.1.2 South America Immuno-oncology Therapy Revenue and Market Share by Countries (2013-2018)

8.2 Brazil Immuno-oncology Therapy Sales and Growth Rate (2013-2018)

8.3 Argentina Immuno-oncology Therapy Sales and Growth Rate (2013-2018)

8.4 Colombia Immuno-oncology Therapy Sales and Growth Rate (2013-2018)

9 Middle East and Africa Immuno-oncology Therapy by Countries

9.1 Middle East and Africa Immuno-oncology Therapy Sales, Revenue and Market Share by Countries

9.1.1 Middle East and Africa Immuno-oncology Therapy Sales and Market Share by Countries (2013-2018)

9.1.2 Middle East and Africa Immuno-oncology Therapy Revenue and Market Share by Countries (2013-2018)

9.2 Saudi Arabia Immuno-oncology Therapy Sales and Growth Rate (2013-2018)

9.3 UAE Immuno-oncology Therapy Sales and Growth Rate (2013-2018)

9.4 Egypt Immuno-oncology Therapy Sales and Growth Rate (2013-2018)

9.5 Nigeria Immuno-oncology Therapy Sales and Growth Rate (2013-2018)

9.6 South Africa Immuno-oncology Therapy Sales and Growth Rate (2013-2018)

10 Global Immuno-oncology Therapy Market Segment by Type

10.1 Global Immuno-oncology Therapy Sales, Revenue and Market Share by Type (2013-2018)

10.1.1 Global Immuno-oncology Therapy Sales and Market Share by Type (2013-2018)

10.1.2 Global Immuno-oncology Therapy Revenue and Market Share by Type (2013-2018)

10.2 Monoclonal Antibodies Sales Growth and Price

10.2.1 Global Monoclonal Antibodies Sales Growth (2013-2018)

10.2.2 Global Monoclonal Antibodies Price (2013-2018)

10.3 Immune Checkpoint Inhibitors Sales Growth and Price

10.3.1 Global Immune Checkpoint Inhibitors Sales Growth (2013-2018)

10.3.2 Global Immune Checkpoint Inhibitors Price (2013-2018)

10.4 Immune System Modulators Sales Growth and Price

10.4.1 Global Immune System Modulators Sales Growth (2013-2018)

10.4.2 Global Immune System Modulators Price (2013-2018)

10.5 Cancer Vaccines Sales Growth and Price

10.5.1 Global Cancer Vaccines Sales Growth (2013-2018)

10.5.2 Global Cancer Vaccines Price (2013-2018)

10.6 Others Sales Growth and Price

10.6.1 Global Others Sales Growth (2013-2018)

10.6.2 Global Others Price (2013-2018)

11 Global Immuno-oncology Therapy Market Segment by Application

11.1 Global Immuno-oncology Therapy Sales Market Share by Application (2013-2018)

11.2 Hospitals Sales Growth (2013-2018)

11.3 Ambulatory Surgical Center Sales Growth (2013-2018)

11.4 Others Sales Growth (2013-2018)

12 Immuno-oncology Therapy Market Forecast (2018-2023)

12.1 Global Immuno-oncology Therapy Sales, Revenue and Growth Rate (2018-2023)

12.2 Immuno-oncology Therapy Market Forecast by Regions (2018-2023)

12.2.1 North America Immuno-oncology Therapy Market Forecast (2018-2023)

12.2.2 Europe Immuno-oncology Therapy Market Forecast (2018-2023)

12.2.3 Asia-Pacific Immuno-oncology Therapy Market Forecast (2018-2023)

12.2.4 South America Immuno-oncology Therapy Market Forecast (2018-2023)

12.2.5 Middle East and Africa Immuno-oncology Therapy Market Forecast (2018-2023)

12.3 Immuno-oncology Therapy Market Forecast by Type (2018-2023)

12.3.1 Global Immuno-oncology Therapy Sales Forecast by Type (2018-2023)

12.3.2 Global Immuno-oncology Therapy Market Share Forecast by Type (2018-2023)

12.4 Immuno-oncology Therapy Market Forecast by Application (2018-2023)

12.4.1 Global Immuno-oncology Therapy Sales Forecast by Application (2018-2023)

12.4.2 Global Immuno-oncology Therapy Market Share Forecast by Application (2018-2023)

13 Sales Channel, Distributors, Traders and Dealers

13.1 Sales Channel

13.1.1 Direct Marketing

13.1.2 Indirect Marketing

13.1.3 Marketing Channel Future Trend

13.2 Distributors, Traders and Dealers

14 Research Findings and Conclusion

15 Appendix

15.1 Methodology

15.2 Data Source

List of Tables and Figures

Figure Immuno-oncology Therapy Picture

Table Product Specifications of Immuno-oncology Therapy

Figure Global Sales Market Share of Immuno-oncology Therapy by Types in 2017<